HC Wainwright Has Pessimistic Outlook of OCUL Q1 Earnings
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Equities researchers at HC Wainwright cut their Q1 2025 earnings estimates for Ocular Therapeutix in a report issued on Tuesday, March 4th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will earn ($0.30) per share for the quarter, down from their previous estimate of […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Equities researchers at HC Wainwright cut their Q1 2025 earnings estimates for Ocular Therapeutix in a report issued on Tuesday, March 4th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will earn ($0.30) per share for the quarter, down from their previous estimate of […]
